Skin and Connective Tissue Diseases Clinical Trial
— MFCOfficial title:
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients as Compared to Controls
Verified date | March 2024 |
Source | Centre Hospitalier Universitaire de Nice |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To compare the level of circulating functional mitochondria in the serum of vitiligo patients as compared to controls
Status | Active, not recruiting |
Enrollment | 59 |
Est. completion date | August 30, 2024 |
Est. primary completion date | April 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Patients with non segmental vitiligo, - atopic dermatitis, psoriais, alopecia areata, - 1st degree relative of vitiligo patients. Exclusion Criteria: - segmental or mixed vitiligo, - personnal history of other autoimmune disorders, - oral use of antioxidant, - pregant women |
Country | Name | City | State |
---|---|---|---|
France | CHU de Nice - Hôpital de l'Archet | Nice | Alpes-maritimes |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nice |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total number of circulating functionnal mitochondria (CFM) in the plasma | Level of CFM in vitiligo serum as compared to controls | at baseline | |
Secondary | measuring the functionality of circulating mitochondria | Functional analysis of CFM in vitiligo patients as compared to controls analyzed by MFI Mito Tracker | At baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04971200 -
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
|
Early Phase 1 | |
Completed |
NCT02379793 -
Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
|
Phase 1 | |
Completed |
NCT01093911 -
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
Completed |
NCT00147511 -
Time To Efficacy and Onset Of Action Of Linezolid
|
Phase 4 | |
Completed |
NCT02355639 -
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
|
Phase 1 | |
Completed |
NCT01764594 -
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
Active, not recruiting |
NCT05185258 -
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
|
Phase 4 | |
Completed |
NCT02985437 -
Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
|
Phase 1 | |
Not yet recruiting |
NCT06427889 -
Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons With Diabetes
|
Phase 4 | |
Completed |
NCT02518048 -
A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
|
Phase 2 | |
Withdrawn |
NCT03196115 -
Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
|
||
Completed |
NCT02416258 -
A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
|
Phase 2 |